Morgan Stanley’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-197,565
Closed -$45K 8139
2022
Q2
$45K Buy
197,565
+141,264
+251% +$53.4K ﹤0.01% 6667
2022
Q1
$33K Sell
56,301
-310,407
-85% -$222K ﹤0.01% 6913
2021
Q4
$377K Sell
366,708
-494,023
-57% -$652K ﹤0.01% 5712
2021
Q3
$1.2M Buy
860,731
+255,514
+42% +$465K ﹤0.01% 4936
2021
Q2
$1.35M Buy
605,217
+112,733
+23% +$263K ﹤0.01% 4912
2021
Q1
$1.41M Sell
492,484
-598,340
-55% -$1.83M ﹤0.01% 4513
2020
Q4
$2.87M Buy
1,090,824
+342,662
+46% +$931K ﹤0.01% 3834
2020
Q3
$1.29M Buy
748,162
+25,176
+3% +$49K ﹤0.01% 4023
2020
Q2
$1.11M Buy
722,986
+43,344
+6% +$64.7K ﹤0.01% 4092
2020
Q1
$944K Buy
679,642
+30,401
+5% +$54.6K ﹤0.01% 4001
2019
Q4
$1.18M Buy
649,241
+74,634
+13% +$177K ﹤0.01% 4425
2019
Q3
$1.58M Sell
574,607
-9,548
-2% -$33.7K ﹤0.01% 3984
2019
Q2
$2.72M Buy
584,155
+362,903
+164% +$1.86M ﹤0.01% 3519
2019
Q1
$1.16M Sell
221,252
-1,053,199
-83% -$6.35M ﹤0.01% 4000
2018
Q4
$6.63M Buy
1,274,451
+1,257,331
+7,344% +$6.59M ﹤0.01% 2556
2018
Q3
$92K Buy
17,120
+15,870
+1,270% +$36K ﹤0.01% 5719
2018
Q2
$2K Sell
1,250
-18,500
-94% -$34.8K ﹤0.01% 6569
2018
Q1
$48K Hold
19,750
﹤0.01% 5895
2017
Q4
$43K Buy
19,750
+17,300
+706% +$40.8K ﹤0.01% 5868
2017
Q3
$8K Sell
2,450
-64,180
-96% -$272K ﹤0.01% 6217
2017
Q2
$342K Buy
66,630
+49,438
+288% +$244K ﹤0.01% 5029
2017
Q1
$71K Buy
+17,192
New +$69.8K ﹤0.01% 5724

Other funds holding NBEV

Morgan Stanley's NBEV Position: Q3 2022 in Review

Morgan Stanley sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q3 2022, closing a stake of 197,565 shares — an estimated $45K sold.

Morgan Stanley first reported a position in NBEV in Q1 2017 and held it in 22 quarters. The position peaked at $6.63M in Q4 2018. 12 funds tracked by Wall St. Rank hold NBEV as of Q3 2022.

  • Morgan Stanley reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q3 2022 after selling out during the quarter.
  • Morgan Stanley sold 197,565 NewAge, Inc. Common Stock (Delaware) shares in Q3 2022, an estimated $45K.
  • Morgan Stanley first reported a position in NewAge, Inc. Common Stock (Delaware) in Q1 2017 and held it in 22 quarters.
  • Morgan Stanley's NewAge, Inc. Common Stock (Delaware) position peaked at $6.63M in Q4 2018.
  • 12 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.